⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5557115 | 1.00 | — | — | |
| SCHEMBL61372 | 1.00 | — | — | |
| SCHEMBL157042 | 0.80 | — | — | |
| SCHEMBL639292 | 0.80 | — | — | |
| SCHEMBL157041 | 0.80 | — | — | |
| SCHEMBL14956926 | 0.78 | ALOX15 (0.43) | — | |
| SCHEMBL17541311 | 0.78 | ALOX15 (0.43) | — | |
| SCHEMBL15676365 | 0.78 | ALOX15 (0.43) | — | |
| SCHEMBL20924801 | 0.74 | ALOX15 (0.37) | — | |
| SCHEMBL7398604 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030147898-A1 | Adjuvant formulation comprising a submicron oil droplet emulson | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2003-08-07 | — | — | US | claimed |
| EP-0489153-B1 | VACCINE COMPOSITIONS CONTAINING LIPOSOMES | CHIRON CORP (US) | 1999-10-13 | — | — | EP | claimed |
| WO-1998009989-A1 | THE USE OF MURAMYLPEPTIDES IN THE TREATMENT OF MYELOSUPPRESSED OR OTHERWISE IMMUNOCOMPROMISED STATES | PEPTECH (UK) LIMITED (GB) | 1998-03-12 | — | — | WO | claimed |
| US-5709879-A | Vaccine compositions containing liposomes | CHIRON CORPORATION (US) | 1998-01-20 | — | — | US | claimed |
| EP-0782454-A1 | USE OF MURAMYL PEPTIDE COMPOUNDS | PEPTECH (UK) (GB) | 1997-07-09 | — | — | EP | claimed |
| EP-0768888-A1 | USE OF MURAMYL PEPTIDE COMPOUNDS | PEPTECH (UK) LIMITED (GB) | 1997-04-23 | — | — | EP | claimed |
| EP-0722332-A1 | COMPOUNDS FOR MEDICINAL USE | PEPTECH (UK) LIMITED (GB) | 1996-07-24 | — | — | EP | claimed |
| WO-1996009063-A1 | USE OF MURAMYL PEPTIDE COMPOUNDS | PEPTECH(UK) LIMITED (GB) | 1996-03-28 | — | — | WO | claimed |
| WO-1996001645-A1 | USE OF MURAMYL PEPTIDE COMPOUNDS | PEPTECH(UK) LIMITED (GB) | 1996-01-25 | — | — | WO | claimed |
| WO-1995010293-A1 | COMPOUNDS FOR MEDICINAL USE | PEPTECH (UK) LIMITED (GB) | 1995-04-20 | — | — | WO | claimed |
| EP-0627928-A1 | USE OF MURAMYL PEPTIDE FOR THE TREATMENT OF TOXICITY | PEPTECH (UK) (GB) | 1994-12-14 | — | — | EP | claimed |
| EP-0399843-B1 | Adjuvant formulation comprising a submicron oil droplet emulsion | CHIRON CORP (US) | 1994-07-13 | — | — | EP | claimed |
| EP-0489153-A4 | VACCINE COMPOSITIONS CONTAINING LIPOSOMES | — | 1993-04-21 | — | — | EP | claimed |
| EP-0280610-B1 | DIPEPTIDES, PREPARATION PROCESS AND USE IN DOSING PROTEASES | SERBIO (FR) | 1992-10-21 | — | — | EP | claimed |
| EP-0489153-A1 | VACCINE COMPOSITIONS CONTAINING LIPOSOMES | CHIRON CORPORATION (US) | 1992-06-10 | — | — | EP | claimed |
| WO-1992000081-A1 | VACCINE COMPOSITIONS CONTAINING LIPOSOMES | CHIRON CORPORATION (US) | 1992-01-09 | — | — | WO | claimed |
| WO-1990014837-A1 | ADJUVANT FORMULATION COMPRISING A SUBMICRON OIL DROPLET EMULSION | CHIRON CORPORATION (US) | 1990-12-13 | — | — | WO | claimed |
| EP-0213523-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING ACYLATED PHOSPHOLIPIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-12-12 | — | — | EP | claimed |
| EP-0399843-A2 | Adjuvant formulation comprising a submicron oil droplet emulsion | CHIRON CORPORATION (US) | 1990-11-28 | — | — | EP | claimed |
| EP-0178624-B1 | LIPOSOMES FROM SYNTHETIC LIPIDS | CIBA-GEIGY AG (CH) | 1990-11-22 | — | — | EP | claimed |